Hewlett-Packard Company (HPQ)’s Data Analytics Deal With Cerner Corporation (CERN)

Hewlett-Packard Company (NYSE:HPQ) recently announced that it had won a major contract from health care IT giant Cerner Corporation (NASDAQ:CERN to upgrade two of its data analytics services. This deal is a positive catalyst for both companies — increasing Hewlett-Packard Company (NYSE:HPQ)’s footprint in the growing health care IT industry while upgrading the performance of Cerner Corporation (NASDAQ:CERN)’s products to remain competitive in an increasingly crowded industry.

Hewlett-Packard Company (NYSE:HPQ)

What the deal means for HP
Like other major IT companies such as International Business Machines Corp. (NYSE:IBMand Accenture Plc (NYSE:ACN), HP has recognized the rising demand for more connected, “smarter” hospitals. The North American health care IT market is expected to grow at a compound annual growth rate of 7.4% by 2017, according to a recent survey. Market research firm Gartner also estimates that the global analytics and business intelligence market will grow 7% year-on-year in 2013.

Hewlett-Packard Company (NYSE:HPQ)’s Vertica Analytics Platform is a core part of the company’s HAVEn initiative, its big data analytics platform. HAVEn is a combination of technologies from HP Autonomy, HP Vertica, HP ArcSight, and other services designed to deliver higher data analytics speeds to clients.

The Cerner Corporation (NASDAQ:CERN) contract will help stabilize Hewlett-Packard Company (NYSE:HPQ)’s Enterprise Services (HP ES) business, which reported a 9% year-on-year decline last quarter despite securing a critical $3.4 billion five-year contract with the U.S. Navy. HP ES was created in 2008 from its $13.9 billion acquisition of EDS. The segment continued growing through acquisitions, including the disastrous $10.3 billion acquisition of Autonomy that caused an $8.8 billion writedown last year.

What the deal means for Cerner
For Cerner Corporation (NASDAQ:CERN), upgrading its data analytics system will ensure that its dependent services — such as EHR (electronic health record) software — remain competitive in an increasingly crowded market. Cerner Corporation (NASDAQ:CERN) is using Hewlett-Packard Company (NYSE:HPQ)’s Vertica Analytics Platform to upgrade the performance of two major services: the Cerner Millennium Architecture and the Cerner Health Facts service.

Millennium is used for delivering patient information to clinicians upon request. Health Facts collects and analyzes patient data to generate information that improves the quality of care at practices. HP Vertica will improve the performance monitoring capabilities of Millennium while boosting the data-handling capacity of Health Facts. Most importantly, HP Vertica will replace Cerner Corporation (NASDAQ:CERN)’s legacy data warehousing solution, which will result in a 100-fold increase in data analytics speed.

Along with voice-recognition technologies from Nuance Technologies which I discussed in a previous article, Cerner’s Millennium and Health Facts solutions will form the backbone for its EHR software. The software unifies patient records on a single platform to improve the efficiency of practices.

Keep an eye on IBM and Accenture
Although Hewlett-Packard Company (NYSE:HPQ) and Cerner’s partnership should prove fruitful for both companies, two other competitors to keep an eye on are International Business Machines Corp. (NYSE:IBM) and Accenture as they are both major players in the data analytics business.

IBM’s most impressive achievement in health care is Watson, the first artificial intelligence medical assistant. Watson received the training of a second-year medical student and “digested” patient records, histories, and research at the renowned Memorial Sloan-Kettering Cancer Center. Through that training, Watson became a medical assistant that could provide treatment options with varying degrees of confidence to clinicians. In other words, while companies like Cerner are accelerating data analytics to enhance EHR software, IBM is using data analytics to fuel the growth of artificial intelligence.

IBM does not report health care revenue separately from services and software, but its 3.3% decline in revenue shows that it is facing similar headwinds as HP in the global enterprise business.

Accenture Plc (NYSE:ACN), a diversified management consulting, technology, and outsourcing company, also recently expanded its footprint in health care IT by acquiring ASM Research, a provider of IT services to U.S. defense and federal health clients. The acquisition is aimed at strengthening U.S. federal health capabilities for military personnel and veterans.

Although the ASM purchase should boost Accenture’s top line in the long run, the company suffered last quarter from its broad diversification. Accenture’s revenue only edged up 0.7% from the prior-year quarter to $7.2 billion, missing the consensus estimate of $7.47 billion. Certain businesses including health care and financial services grew, but others declined and offset those gains.

A Foolish final thought
Although the world of health care IT is growing, it’s not a 100-meter dash to the finish line. The effort to modernize hospitals through faster data analytics, streamlined EHRs, ICD-10 updates, and better wireless networks will be a long, grueling marathon. Investors should expect sluggish, single-digit sales growth from most of these companies over the next few years. Long-term growth should remain positive as they secure more contracts, however.

As seen with HP and Accenture, exposure to other businesses can be a drag on stabilizing or growing their data analytics businesses. Therefore, investors who want better exposure to the growing health care IT market without the unwanted weight of slow-growth businesses should stick with dedicated health care IT companies like Cerner instead.

The article Analyzing HP’s Data Analytics Deal With Cerner originally appeared on Fool.com and is written by Leo Sun.

Leo Sun has no position in any stocks mentioned. The Motley Fool recommends Accenture. The Motley Fool owns shares of International Business Machines (NYSE:IBM).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!